Lipid14: the amber lipid force field CJ Dickson, BD Madej, ÅA Skjevik, RM Betz, K Teigen, IR Gould, ... Journal of chemical theory and computation 10 (2), 865-879, 2014 | 1279 | 2014 |
LIPID11: a modular framework for lipid simulations using amber ÅA Skjevik, BD Madej, RC Walker, K Teigen The Journal of Physical Chemistry B 116 (36), 11124-11136, 2012 | 230 | 2012 |
A de novo compound targeting α-synuclein improves deficits in models of Parkinson’s disease W Wrasidlo, IF Tsigelny, DL Price, G Dutta, E Rockenstein, TC Schwarz, ... Brain 139 (12), 3217-3236, 2016 | 154 | 2016 |
Next‐generation sequencing of circulating tumor DNA reveals frequent alterations in advanced hepatocellular carcinoma S Ikeda, IF Tsigelny, ÅA Skjevik, Y Kono, M Mendler, A Kuo, JK Sicklick, ... The oncologist 23 (5), 586-593, 2018 | 83 | 2018 |
All-atom lipid bilayer self-assembly with the AMBER and CHARMM lipid force fields ÅA Skjevik, BD Madej, CJ Dickson, K Teigen, RC Walker, IR Gould Chemical communications 51 (21), 4402-4405, 2015 | 68 | 2015 |
Intramolecular hydrogen bonding in articaine can be related to superior bone tissue penetration: a molecular dynamics study ÅA Skjevik, BE Haug, H Lygre, K Teigen Biophysical Chemistry 154 (1), 18-25, 2011 | 58 | 2011 |
Simulation of lipid bilayer self-assembly using all-atom lipid force fields ÅA Skjevik, BD Madej, CJ Dickson, C Lin, K Teigen, RC Walker, IR Gould Physical Chemistry Chemical Physics 18 (15), 10573-10584, 2016 | 57 | 2016 |
The N-terminal sequence of tyrosine hydroxylase is a conformationally versatile motif that binds 14-3-3 proteins and membranes ÅA Skjevik, M Mileni, A Baumann, Ø Halskau, K Teigen, RC Stevens, ... Journal of molecular biology 426 (1), 150-168, 2014 | 42 | 2014 |
Water exit pathways and proton pumping mechanism in B-type cytochrome c oxidase from molecular dynamics simulations L Yang, ÅA Skjevik, WGH Du, L Noodleman, RC Walker, AW Götz Biochimica et Biophysica Acta (BBA)-Bioenergetics 1857 (9), 1594-1606, 2016 | 21 | 2016 |
Data for molecular dynamics simulations of B-type cytochrome c oxidase with the Amber force field L Yang, ÅA Skjevik, WGH Du, L Noodleman, RC Walker, AW Götz Data in Brief 8, 1209-1214, 2016 | 16 | 2016 |
Overview of computational methods employed in early-stage drug discovery ÅA Skjevik, K Teigen, A Martinez Future Medicinal Chemistry 1 (1), 49-63, 2009 | 12 | 2009 |
Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone SI Støve, ÅA Skjevik, K Teigen, A Martinez Communications Biology 5 (1), 1283, 2022 | 11 | 2022 |
BRAF mutation as a novel driver of eosinophilic cystitis MY Choi, IF Tsigelny, A Boichard, ÅA Skjevik, A Shabaik, R Kurzrock Cancer Biology & Therapy 18 (9), 655-659, 2017 | 6 | 2017 |
Molecular dynamics use in personalized cancer medicine: example of MET Y501C mutation IF Tsigelny, R Kurzrock, ÅA Skjevik, VL Kouznetsova, S Ikeda 2016 6th International Conference on Simulation and Modeling Methodologies …, 2016 | 2 | 2016 |
Correction to: A de novo compound targeting α-synuclein improves deficits in models of Parkinson’s disease W Wrasidlo, IF Tsigelny, DL Price, G Dutta, E Rockenstein, TC Schwarz, ... Brain 146, e92-e93, 2023 | | 2023 |
Investigating the Disordered and Membrane-Active Peptide A-Cage-C Using Conformational Ensembles O Dobrovolska, Ø Strømland, ØS Handegård, M Jakubec, ML Govasli, ... Molecules 26 (12), 3607, 2021 | | 2021 |
Proteins Flexibility as a Criterion for Elucidation of Activating Mutants in Personalized Cancer Medicine IF Tsigelny, R Kurzrock, ÅA Skjevik, VL Kouznetsova, A Boichard, S Ikeda Simulation and Modeling Methodologies, Technologies and Applications …, 2018 | | 2018 |
1.132 TYROSINE HYDROXYLASE INTERACTING WITH PHOSPHOLIPID MEMBRANES: A MOLECULAR DYNAMICS STUDY ÅA Skjevik, M Ying, A Martinez, K Teigen Parkinsonism and Related Disorders, S43, 2012 | | 2012 |